Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #11, November 2002
Appellate Court Overturns District Court's Decision Based on the Incorrect Application of Judicial Estoppel
The U.S. Court of Appeals for the Eighth Circuit reversed a district court's decision to grant summary judgment to the manufacturer of Parlodel on grounds that the court incorrectly applied the doctrine of judicial estoppel to preclude the appellants fro
A Louisiana woman who claims to have suffered ''serious and permanent damage to her health'' as a result of using the drug Imitrex to treat her migraine headaches has sued the drug's manufacturer.
The manufacturers' response to a DES products liability complaint states that the plaintiffs faile to state a claim upon which relief can be granted and that any alleged injuries were caused by the improper use of the product.
Louisiana Woman Claims Serzone Manufacturer Failed to Provide Adequate Warnings Concerning Liver Damage
Bristol-Myers Squibb Co., the manufacturer of Serzone, allegedly marketed and sold a defective product and failed to adequately warn consumers and physicians of the antidepressant's ability to cause liver failure and liver necrosis, a Louisiana woman clai
BASF Corporation, a subsidiary of Abbott Laboratories, the manufacturer of Meridia, responded to the claims of a class action complaint filed by an individual who allegedly suffered injuries as a result of using the weight loss drug.
A motion to conduct ex parte interviews with the treating physicians of individuals who claim they became addicted to Oxycontin was denied by a federal judge, who ruled that a physician's information regarding the physical and mental health of a patient c
The manufacturers of Oxycontin claim in a recent removal notice alleging fraudulent joinder that a man who allegedly suffered addiction to the prescription painkiller failed to state sufficient legal claims against the physician who prescribed the drug, t
A Louisiana woman's wrongful death action filed against the makers of Oxycontin should be heard in federal court because the plaintiffs' failed to mention her citizenship, the manufacturer claims.
For the second time this year, U.S. District Judge Danny C. Reeves denied certification to a proposed class of individuals who claim they allegedly suffered from injuries as a result on ingesting Oxycontin.
The plaintiffs involved in the nation's first Oxycontin-based products liability lawsuit voluntarily dismissed their claims with prejudice weeks before the case was scheduled to go to trial.